Gelteq Limited Ordinary Shares (GELS) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Gelteq Limited Ordinary Shares (GELS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $4.9M, listed on NASDAQ, employing roughly 18 people, carrying a beta of -0.54 to the broader market. Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. Led by Nathan Jacob Givoni, public since 2024-10-29.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for GELS as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.